Comparison between Bio Medica Laboratories IPO and Diksha Polymers IPO.
Bio Medica Laboratories IPO is a SME Fixed Price IPO proposed to list at NSE SME while Diksha Polymers IPO is a SME Fixed Price proposed to list at BSE SME.
| Bio Medica Laboratories IPO | Diksha Polymers IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Fixed Price |
| Listing At | NSE SME | BSE SME |
| Lead Managers | Narnolia Financial Services Ltd. | Aryaman Financial Services Ltd. |
| Registrar | Skyline Financial Services Pvt.Ltd. | Cameo Corporate Services Ltd. |
| Market Maker | Prabhat Financial Services Ltd. | Shreni Shares Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Bio Medica Laboratories IPO is up to ₹49.80 Cr whereas the issue size of the Diksha Polymers IPO is up to ₹16.99 Cr. The final issue price of Bio Medica Laboratories IPO is ₹139.00 per share and of Diksha Polymers IPO is ₹112.00 per share.
| Bio Medica Laboratories IPO | Diksha Polymers IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹132.00 per share | |
| Issue Price (Upper) | ₹139.00 per share | |
| Issue Price (Final) | ₹139.00 per share | ₹112.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 1000 shares | 1200 shares |
| Fresh Issue Size | 32,06,000 shares | 15,16,800 shares |
| Fresh Issue Size (Amount) | up to ₹44.56 Cr | up to ₹16.99 Cr |
| OFS Issue Size | 3,77,000 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹5.24 Cr | up to ₹0.00 Cr |
| Issue Size Total | 35,83,000 shares | 15,16,800 shares |
| Issue Size Total (Amount) | up to ₹49.80 Cr | up to ₹16.99 Cr |
Bio Medica Laboratories IPO opens on May 21, 2026, while Diksha Polymers IPO opens on Jun 17, 2026. The closing date of Bio Medica Laboratories IPO and Diksha Polymers IPO is May 25, 2026, and Jun 19, 2026, respectively.
| Bio Medica Laboratories IPO | Diksha Polymers IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | May 21, 2026 | Jun 17, 2026 |
| Issue Close | May 25, 2026 | Jun 19, 2026 |
| Basis Of Allotment (Tentative) | May 26, 2026 | Jun 22, 2026 |
| Initiation of Refunds (Tentative) | May 27, 2026 | Jun 23, 2026 |
| Credit of Share (Tentative) | May 27, 2026 | Jun 23, 2026 |
| Listing date (Tentative) | May 29, 2026 | Jun 24, 2026 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Bio Medica Laboratories IPO P/E ratio is 13.03, as compared to Diksha Polymers IPO P/E ratio of 9.79.
| Bio Medica Laboratories IPO | Diksha Polymers IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated)Diksha Polymers Ltd.'s revenue increased by 20% and profit after tax (PAT) rose by 56% between the financial year ending with March 31, 2026 and March 31, 2025.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 96.84 | 100 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 69.25 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 13.03 | 9.79 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹174.79 Cr. | ₹58.20 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 99.59 | 48.32 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 48.20 | 28.09 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.02 | 1.77 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹10.67 | ₹11.44 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 99.59 | 48.32 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Bio Medica Laboratories IPO Retail Individual Investors (RII) are offered 17,92,000 shares while in Diksha Polymers IPO retail investors are offered 17,92,000 shares. Qualified Institutional Buyers (QIB) are offered 36,000 shares in Bio Medica Laboratories IPO and 0 shares in Diksha Polymers IPO.
| Bio Medica Laboratories IPO | Diksha Polymers IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 1,89,000 shares | 81,600 shares |
| QIB | 36,000 shares | 0 shares |
| NII | 17,55,000 shares | 7,58,400 shares |
| RII | 17,92,000 shares | 7,58,400 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 35,83,000 shares | 15,16,800 shares |
Bio Medica Laboratories IPO subscribed 2.26x in total, whereas Diksha Polymers IPO subscribed 2.88x.
| Bio Medica Laboratories IPO | Diksha Polymers IPO | |
|---|---|---|
| QIB (times) | 15.94x | |
| NII (times) | 1.30x | 2.63x |
| Big NII (times) | 0.86x | |
| Small NII (times) | 2.19x | |
| RII (times) | 2.92x | 3.14x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 2.26x | 2.88x |
